Table 2 Alteration of vision and retinal and choroidal parameters following laser treatment.

From: Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy

Variables

Overall

(mean ± SD)

FA–guided

PDT

(mean ± S)

IGCA–guided

PDT

(mean ± SD)

Intergroup P-value

BCVA

(logMAR)

Baseline

0.49 ± 0.40

0.34 ± 0.26

0.56 ± 0.43

0.132—

4th month

0.33 ± 0.41

0.14 ± 0.13

0.43 ± 0.47

0.160†

Change

Ā 

āˆ’ā€‰0.19 ± 0.05

āˆ’ā€‰0.13 ± 0.02

Ā 

Intragroup P-value

0.005*

0.001*

Ā 

choroidal area

(mm2)

Baseline

0.47 ± 0.10

0.46 ± 0.13

0.48 ± 0.86

0.630§

4th month

0.39 ± 0.08

0.36 ± 0.08

0.40 ± 0.81

0.320†

Change

Ā 

0.09 ± 0.07

0.07 ± 0.05

Ā 

Intragroup P-value

0.001**

< 0.001**

Ā 

PED area

(mm2)

Baseline

0.34 ± 0.49

0.19 ± 0.04

0.40 ± 0.16

0.959—

4th month

0.19 ± 0.39

0.07 ± 0.08

0.24 ± 0.46

0.930†

Change

Ā 

āˆ’ā€‰0.12 ± 0.03

āˆ’ā€‰0.16 ± 0.14

Ā 

Intragroup P-value

0.040*

0.002*

Ā 

SFCT

(µm)

Baseline

354 ± 54

338 ± 38

363 ± 60

0.251—

4th month

275 ± 46

277 ± 44

274 ± 48

0.101†

Change

Ā 

61 ± 33

88 ± 51

Ā 

Intragroup P-value

0.001*

0.001*

Ā 

CVI

Baseline

81.16 ± 5.43

81.00 ± 4.44

81.25 ± 5.98

0.896§

4th month

77.45 ± 5.04

76.16 ± 4.60

78.13 ± 5.23

0.174†

Change

Ā 

āˆ’ā€‰4.83 ± 2.83

āˆ’ā€‰3.12 ± 3.15

Ā 

Intragroup P-value

0.001**

0.001**

Ā 

CMT

(µm)

Baseline

334 ± 108

340 ± 115

332 ± 108

0.650—

month

202 ± 63

195 ± 37

207 ± 74

0.478†

Change

Ā 

144 ± 109

124 ± 67

Ā 

Intragroup P-value

0.002*

0.001*

Ā 
  1. Analyzed by: *Wilcoxon test, — Mann–Whitney U, †ANCOVA, §Independent sample t test, **paired sample t test.
  2. SFCT Subfoveal choroidal thickness, CVI Choroidal vascular index, CMT Central macular thickness.